Biote (BTMD) Gains from Investment Securities (2021 - 2026)

Biote (BTMD) has reported Gains from Investment Securities for 6 consecutive years, with $11.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Gains from Investment Securities changed N/A year-over-year to $11.5 million; the TTM figure through Mar 2026 stood at $11.5 million (changed N/A YoY), while the FY2025 annual figure was $2.6 million, down 75.19% from the prior year.
• Gains from Investment Securities came in at $11.5 million for Q1 2026 at Biote, up from $2.6 million in the prior quarter.
• The five-year high for Gains from Investment Securities was $11.8 million in Q2 2023, with the low at -$3.4 million in Q2 2022.
• Average Gains from Investment Securities over 5 years is $2.6 million, with a median of $420212.0 recorded in 2024.
• Across the five-year window, Gains from Investment Securities slumped 2768.98% in 2022 and jumped 446.95% in 2023, its largest moves.
• Year by year, Gains from Investment Securities stood at -$575000.0 in 2022, then soared by 748.28% to $3.7 million in 2023, then soared by 176.6% to $10.3 million in 2024, then sank by 75.19% to $2.6 million in 2025, then soared by 349.24% to $11.5 million in 2026.
• According to Business Quant data, Gains from Investment Securities over the past three periods registered $11.5 million, $2.6 million, and $4.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.